Integrated Drug Discovery Programs

Navigating drug candidates through the full drug discovery and development continuum requires the right level of experience to enable confirmation of favorable characteristics and identification of unfavorable attributes early on in discovery phases.

Towards this effort, early drug discovery programs are comprised of these 4 general areas of focus:

  • Validation of Drug Target and Intervention Strategy
  • Selection of Chemical Series
  • Development of Biomarker Strategy
  • Qualifying Safety and Tolerability

Inotiv’s team of industry experienced scientists harness the importance of these areas needed to help navigate your molecule through the foundational discovery stages of drug development. We offer a comprehensive array of in vitro and in vivo study designs and execution including disease pharmacology, DMPK, bioanalysis, cell and molecular biology, exploratory toxicology, and histopathology. Supported by Inotiv’s wealth of experience and collaborative approach, you can be confident when making timely data-driven go/no-go decisions with your studies.

Take advantage of our long and impeccable history, world-class team of industry scientists, and track record of providing fit-for-purpose solutions essential to the success of your Drug Discovery Program.